Terhaard C - Search Results

1

Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.

de Roest RH, van der Heijden M, Wesseling FWR, de Ruiter EJ, Heymans MW, Terhaard C, Vergeer MR, Buter J, Devriese LA, de Boer JP, Navran A, Hoeben A, Vens C, van den Brekel M, Brakenhoff RH, Leemans CR, Hoebers F. de Roest RH, et al. Among authors: terhaard c. Radiother Oncol. 2022 Oct;175:112-121. doi: 10.1016/j.radonc.2022.08.013. Epub 2022 Aug 13. Radiother Oncol. 2022. PMID: 35973619 Free article.

2

T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results.

Terhaard CH, Hordijk GJ, van den Broek P, de Jong PC, Snow GB, Hilgers FJ, Annyas BA, Tjho-Heslinga RE, de Jong JM. Terhaard CH, et al. Clin Otolaryngol Allied Sci. 1992 Oct;17(5):393-402. doi: 10.1111/j.1365-2273.1992.tb01681.x. Clin Otolaryngol Allied Sci. 1992. PMID: 1458620 Review.

3

The importance of vocal cord mobility in T2 laryngeal cancer.

Wiggenraad RG, Terhaard CH, Hordijk GJ, Ravasz LA. Wiggenraad RG, et al. Among authors: terhaard ch. Radiother Oncol. 1990 Aug;18(4):321-7. doi: 10.1016/0167-8140(90)90112-a. Radiother Oncol. 1990. PMID: 2244019

4

Degree of tumour differentiation as a prognostic factor in advanced laryngeal cancer.

Geelen CP, Hordijk GJ, Ravasz LA, Terhaard CH. Geelen CP, et al. Among authors: terhaard ch. Acta Otorhinolaryngol Belg. 1995;49(1):1-4. Acta Otorhinolaryngol Belg. 1995. PMID: 7725912

5

CT-based parotid gland location: implications for preservation of parotid function.

Roesink JM, Terhaard CH, Moerland MA, van Iersel F, Battermann JJ. Roesink JM, et al. Among authors: terhaard ch. Radiother Oncol. 2000 May;55(2):131-3. doi: 10.1016/s0167-8140(00)00154-7. Radiother Oncol. 2000. PMID: 10799724

6

The dose to the parotid glands with IMRT for oropharyngeal tumors: the effect of reduction of positioning margins.

van Asselen B, Dehnad H, Raaijmakers CP, Roesink JM, Lagendijk JJ, Terhaard CH. van Asselen B, et al. Radiother Oncol. 2002 Aug;64(2):197-204. doi: 10.1016/s0167-8140(02)00152-4. Radiother Oncol. 2002. PMID: 12242130

7

Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma.

Waaijer A, Terhaard CH, Dehnad H, Hordijk GJ, van Leeuwen MS, Raaymakers CP, Lagendijk JJ. Waaijer A, et al. Radiother Oncol. 2003 Mar;66(3):271-6. doi: 10.1016/s0167-8140(03)00036-7. Radiother Oncol. 2003. PMID: 12742266

8

Segmental IMRT for oropharyngeal cancer in a clinical setting.

van Asselen B, Dehnad H, Terhaard CH, Lagendijk JJ, Raaijmakers CP. van Asselen B, et al. Radiother Oncol. 2003 Dec;69(3):259-66. doi: 10.1016/j.radonc.2003.09.008. Radiother Oncol. 2003. PMID: 14644485

9

Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital.

Langenberg M, Terhaard CH, Hordijk GJ, Es RJ, Voest EE, Graeff A. Langenberg M, et al. Among authors: terhaard ch. Clin Otolaryngol Allied Sci. 2004 Dec;29(6):729-34. doi: 10.1111/j.1365-2273.2004.00892.x. Clin Otolaryngol Allied Sci. 2004. PMID: 15533169

10

Does 4 MV perform better compared to 6 MV in the presence of air cavities in the head and neck region?

Petoukhova AL, Terhaard CH, Welleweerd H. Petoukhova AL, et al. Radiother Oncol. 2006 May;79(2):203-7. doi: 10.1016/j.radonc.2006.04.002. Epub 2006 May 15. Radiother Oncol. 2006. PMID: 16698100

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page